News Novartis cancer drugs among raft of NICE recommendations NICE recommends funding for lung cancer and skin cancer treatments.
News GSK COPD combination better than AZ rival - trial GSK plans to file triple combination therapy by end of the year.
News Circassia shares plummet following cat allergy therapy failu... Company said the failure could have implications for its other products under development
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
